Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Multiple Sclerosis”

1,179 trials

Showing 20 of 1,179 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Early research (Phase 1)Study completedNCT01803867
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 72
Large-scale testing (Phase 3)Study completedNCT01707992
What this trial is testing

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 2,199
Large-scale testing (Phase 3)Looking for participantsNCT06008249
What this trial is testing

Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Stichting TRICALS Foundation 171
Not applicableUnknownNCT05075499
What this trial is testing

Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 70
Not applicableWithdrawnNCT01453764
What this trial is testing

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisAutoimmune DiseasesAutoimmune Diseases of the Nervous System+1 more
Ageless Regenerative Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06392009
What this trial is testing

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

Who this might be right for
Tuberous Sclerosis ComplexFocal Cortical Dysplasia
GRIN Therapeutics, Inc. 30
Not applicableStudy completedNCT03637699
What this trial is testing

A Positive Psychology Intervention for Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Brigham and Women's Hospital 30
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Not applicableStudy completedNCT06051019
What this trial is testing

Effect of Aerobic Training vs Balance Training on Fatigue Symptom in Multiple Sclerosis Patient (FATI-gate)

Who this might be right for
Multiple Sclerosis
Istituto Auxologico Italiano 39
Post-approval studies (Phase 4)Study completedNCT02048072
What this trial is testing

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Who this might be right for
Multiple SclerosisAutonomic Nervous System Dysfunction
Jochen Vehoff 33
Large-scale testing (Phase 3)Study completedNCT00134563
What this trial is testing

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,088
Not applicableStudy completedNCT05366036
What this trial is testing

Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Eisai Korea Inc. 172
Large-scale testing (Phase 3)Study completedNCT01665144
What this trial is testing

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Who this might be right for
Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals 1,651
Not applicableStudy completedNCT05286632
What this trial is testing

KidneYou - Innovative Digital Therapy

Who this might be right for
Chronic Kidney DiseasesDiabetesArterial Hypertension+10 more
Advice Pharma Group srl 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT05054140
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immunic AG 450
Testing effectiveness (Phase 2)Study completedNCT02782858
What this trial is testing

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GeNeuro SA 270
Not applicableStudy completedNCT03451955
What this trial is testing

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Who this might be right for
Optic NeuritisMultiple SclerosisClinically Isolated Syndrome
University of Copenhagen 103
Not applicableStudy completedNCT01456416
What this trial is testing

Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of Southern California 10
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation